These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
356 related articles for article (PubMed ID: 20519123)
1. Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor. Rauch A; Seitz S; Baschant U; Schilling AF; Illing A; Stride B; Kirilov M; Mandic V; Takacz A; Schmidt-Ullrich R; Ostermay S; Schinke T; Spanbroek R; Zaiss MM; Angel PE; Lerner UH; David JP; Reichardt HM; Amling M; Schütz G; Tuckermann JP Cell Metab; 2010 Jun; 11(6):517-31. PubMed ID: 20519123 [TBL] [Abstract][Full Text] [Related]
2. Dicer ablation in osteoblasts by Runx2 driven cre-loxP recombination affects bone integrity, but not glucocorticoid-induced suppression of bone formation. Liu P; Baumgart M; Groth M; Wittmann J; Jäck HM; Platzer M; Tuckermann JP; Baschant U Sci Rep; 2016 Aug; 6():32112. PubMed ID: 27554624 [TBL] [Abstract][Full Text] [Related]
3. An anti-inflammatory selective glucocorticoid receptor modulator preserves osteoblast differentiation. Rauch A; Gossye V; Bracke D; Gevaert E; Jacques P; Van Beneden K; Vandooren B; Rauner M; Hofbauer LC; Haegeman G; Elewaut D; Tuckermann JP; De Bosscher K FASEB J; 2011 Apr; 25(4):1323-32. PubMed ID: 21233489 [TBL] [Abstract][Full Text] [Related]
4. Suppressive effect of dexamethasone on TIMP-1 production involves murine osteoblastic MC3T3-E1 cell apoptosis. Xie H; Tang LL; Luo XH; Wu XY; Wu XP; Zhou HD; Yuan LQ; Liao EY Amino Acids; 2010 Apr; 38(4):1145-53. PubMed ID: 19629637 [TBL] [Abstract][Full Text] [Related]
5. [Action of glucocorticoid on bone-forming and bone-resorbing cells]. Hakeda Y Clin Calcium; 2006 Nov; 16(11):1817-22. PubMed ID: 17079848 [TBL] [Abstract][Full Text] [Related]
6. Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures. Luppen CA; Smith E; Spevak L; Boskey AL; Frenkel B J Bone Miner Res; 2003 Jul; 18(7):1186-97. PubMed ID: 12854828 [TBL] [Abstract][Full Text] [Related]
7. Parathyroid hormone (1-34) counteracts the suppression of interleukin-11 expression by glucocorticoid in murine osteoblasts: a possible mechanism for stimulating osteoblast differentiation against glucocorticoid excess. Kuriwaka-Kido R; Kido S; Miyatani Y; Ito Y; Kondo T; Omatsu T; Dong B; Endo I; Miyamoto K; Matsumoto T Endocrinology; 2013 Mar; 154(3):1156-67. PubMed ID: 23397032 [TBL] [Abstract][Full Text] [Related]
9. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation. Wang X; Wu J; Shidoji Y; Muto Y; Ohishi N; Yagi K; Ikegami S; Shinki T; Udagawa N; Suda T; Ishimi Y J Bone Miner Res; 2002 Jan; 17(1):91-100. PubMed ID: 11771673 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of glycogen synthase kinase-3beta attenuates glucocorticoid-induced bone loss. Wang FS; Ko JY; Weng LH; Yeh DW; Ke HJ; Wu SL Life Sci; 2009 Nov; 85(19-20):685-92. PubMed ID: 19782693 [TBL] [Abstract][Full Text] [Related]
11. [Glucocorticoid and Bone. The effect of glucocorticoid and PTH in osteoblast apoptosis and differentiation via interleukin 11 expression]. Endo I Clin Calcium; 2014 Sep; 24(9):1321-8. PubMed ID: 25177004 [TBL] [Abstract][Full Text] [Related]
12. A critical role for interleukin-6 family-mediated Stat3 activation in osteoblast differentiation and bone formation. Itoh S; Udagawa N; Takahashi N; Yoshitake F; Narita H; Ebisu S; Ishihara K Bone; 2006 Sep; 39(3):505-12. PubMed ID: 16679075 [TBL] [Abstract][Full Text] [Related]
13. The activated glucocorticoid receptor inhibits the transcription factor T-bet by direct protein-protein interaction. Liberman AC; Refojo D; Druker J; Toscano M; Rein T; Holsboer F; Arzt E FASEB J; 2007 Apr; 21(4):1177-88. PubMed ID: 17215482 [TBL] [Abstract][Full Text] [Related]
14. Role of apoptosis in glucocorticoid-induced osteoporosis and osteonecrosis. Zalavras C; Shah S; Birnbaum MJ; Frenkel B Crit Rev Eukaryot Gene Expr; 2003; 13(2-4):221-35. PubMed ID: 14696969 [TBL] [Abstract][Full Text] [Related]
15. Selective glucocorticoid receptor modulation maintains bone mineral density in mice. Thiele S; Ziegler N; Tsourdi E; De Bosscher K; Tuckermann JP; Hofbauer LC; Rauner M J Bone Miner Res; 2012 Nov; 27(11):2242-50. PubMed ID: 22714558 [TBL] [Abstract][Full Text] [Related]
16. Endogenous TNFalpha lowers maximum peak bone mass and inhibits osteoblastic Smad activation through NF-kappaB. Li Y; Li A; Strait K; Zhang H; Nanes MS; Weitzmann MN J Bone Miner Res; 2007 May; 22(5):646-55. PubMed ID: 17266397 [TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid receptor signaling in bone cells. Moutsatsou P; Kassi E; Papavassiliou AG Trends Mol Med; 2012 Jun; 18(6):348-59. PubMed ID: 22578718 [TBL] [Abstract][Full Text] [Related]
18. Glucocorticoid receptor and Histone deacetylase 6 mediate the differential effect of dexamethasone during osteogenesis of mesenchymal stromal cells (MSCs). Rimando MG; Wu HH; Liu YA; Lee CW; Kuo SW; Lo YP; Tseng KF; Liu YS; Lee OK Sci Rep; 2016 Nov; 6():37371. PubMed ID: 27901049 [TBL] [Abstract][Full Text] [Related]
19. Identification of endogenous glucocorticoid repressed genes differentially regulated by a glucocorticoid receptor mutant able to separate between nuclear factor-kappaB and activator protein-1 repression. Bladh LG; Lidén J; Dahlman-Wright K; Reimers M; Nilsson S; Okret S Mol Pharmacol; 2005 Mar; 67(3):815-26. PubMed ID: 15550679 [TBL] [Abstract][Full Text] [Related]
20. Glucocorticoid receptor dimerization is required for survival in septic shock via suppression of interleukin-1 in macrophages. Kleiman A; Hübner S; Rodriguez Parkitna JM; Neumann A; Hofer S; Weigand MA; Bauer M; Schmid W; Schütz G; Libert C; Reichardt HM; Tuckermann JP FASEB J; 2012 Feb; 26(2):722-9. PubMed ID: 22042221 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]